1. Aberrant DNA methylations in chondrosarcoma. (November 2016) Authors: Liu, Pei; Shen, Jacson K; Xu, Jianzhong; Trahan, Carol A; Hornicek, Francis J; Duan, Zhenfeng Journal: Epigenomics Issue: Volume 8:Number 11(2016) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aberrant DNA methylations in chondrosarcoma. (November 2016) Authors: Liu, Pei; Shen, Jacson K; Xu, Jianzhong; Trahan, Carol A; Hornicek, Francis J; Duan, Zhenfeng Journal: Epigenomics Issue: Volume 8:Number 11(2016) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications. (February 2018) Authors: Xiao, Xin; Garbutt, Cassandra C.; Hornicek, Francis; Guo, Zheng; Duan, Zhenfeng Journal: Cancer treatment reviews Issue: Volume 63(2018) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Advances in sarcoma gene mutations and therapeutic targets. (January 2018) Authors: Gao, Peng; Seebacher, Nicole A.; Hornicek, Francis; Guo, Zheng; Duan, Zhenfeng Journal: Cancer treatment reviews Issue: Volume 62(2018) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma. Issue 4 (15th February 2019) Authors: Wang, Gangyang; Sun, Mengxiong; Jiang, Yafei; Zhang, Tao; Sun, Wei; Wang, Hongsheng; Yin, Fei; Wang, Zhuoying; Sang, Weilin; Xu, Jing; Mao, Min; Zuo, Dongqing; Zhou, Zifei; Wang, Chongren; Fu, Zeze; Wang, Zongyi; Duan, Zhenfeng; Hua, Yingqi; Cai, Zhengdong Journal: International journal of cancer Issue: Volume 145:Issue 4(2019) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future. (28th December 2018) Authors: Li, Xiaoyang; Seebacher, Nicole A.; Hornicek, Francis J.; Xiao, Tao; Duan, Zhenfeng Journal: Cancer letters Issue: Volume 439(2019) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Application of metabolomics in sarcoma: From biomarkers to therapeutic targets. (August 2017) Authors: Min, Li; Choy, Edwin; Tu, Chongqi; Hornicek, Francis; Duan, Zhenfeng Journal: Critical reviews in oncology/hematology Issue: Volume 116(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer. (December 2020) Authors: Feng, Wenlong; Dean, Dylan C.; Hornicek, Francis J.; Wang, Jinglu; Jia, Yanyan; Duan, Zhenfeng; Shi, Huirong Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BRAF mutation in 'sarcomas': a possible method to detect de‐differentiated melanomas. Issue 5 (7th December 2013) Authors: Cipriani, Nicole A; Letovanec, Igor; Hornicek, Francis J; Mullen, John T; Duan, Zhenfeng; Borger, Darrell R; Nielsen, Gunnlaugur Petur Journal: Histopathology Issue: Volume 64:Issue 5(2014) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application. (1st June 2020) Authors: Wei, Ran; Dean, Dylan C.; Thanindratarn, Pichaya; Hornicek, Francis J.; Guo, Wei; Duan, Zhenfeng Journal: Cancer letters Issue: Volume 479(2020) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗